{"transactions":[{"id":946931,"issuer":{"id":4602,"kind":"organization","name":"Damora Therapeutics, Inc.","symbol":"DMRA"},"owners":[{"id":70026,"kind":"person","name":"Firmani Lori","position":1,"cik":"0001808248","reported_name":"Firmani Lori","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2026-01-06T21:30:10.000Z","date":"2026-01-02","kind":"exercise","planned":false,"acquired":false,"shares":374,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents the right to receive, at settlement, one share of common stock of the Issuer. This transaction represents the settlement of RSUs in shares of common stock on their scheduled vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This award was granted on January 3, 2024. One-third of the RSUs subject to the award vested on January 3, 2025 and one-sixth of the RSUs subject to the award award will vest ratably every six months thereafter, assuming continued employment through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"This award was granted on January 3, 2024. One-third of the RSUs subject to the award vested on January 3, 2025 and one-sixth of the RSUs subject to the award award will vest ratably every six months thereafter, assuming continued employment through the applicable vesting date."}],"balance_after":726,"derivative":{"underlying":"Common Stock","underlying_shares":374},"source":{"system":"sec-edgar","filing":"0001193125-26-004565","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1808248/000119312526004565/ownership.xml","form_type":"4"}},{"id":946930,"issuer":{"id":4602,"kind":"organization","name":"Damora Therapeutics, Inc.","symbol":"DMRA"},"owners":[{"id":70026,"kind":"person","name":"Firmani Lori","position":1,"cik":"0001808248","reported_name":"Firmani Lori","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-01-06T21:30:10.000Z","date":"2026-01-02","kind":"sale","planned":false,"acquired":false,"shares":135,"price":21.41,"value":2890.35,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares sold to cover tax obligations in connection with the vesting of the RSUs listed in Table II. This sale is mandated by the Issuer's election under its 2020 Equity Incentive Plan and does not represent a discretionary trade by the Reporting Person."}],"balance_after":931,"source":{"system":"sec-edgar","filing":"0001193125-26-004565","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808248/000119312526004565/ownership.xml","form_type":"4"}},{"id":946929,"issuer":{"id":4602,"kind":"organization","name":"Damora Therapeutics, Inc.","symbol":"DMRA"},"owners":[{"id":70026,"kind":"person","name":"Firmani Lori","position":1,"cik":"0001808248","reported_name":"Firmani Lori","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-01-06T21:30:10.000Z","date":"2026-01-02","kind":"exercise","planned":false,"acquired":true,"shares":374,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents the right to receive, at settlement, one share of common stock of the Issuer. This transaction represents the settlement of RSUs in shares of common stock on their scheduled vesting date."}],"balance_after":1066,"source":{"system":"sec-edgar","filing":"0001193125-26-004565","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808248/000119312526004565/ownership.xml","form_type":"4"}},{"id":1090682,"issuer":{"id":4602,"kind":"organization","name":"Damora Therapeutics, Inc.","symbol":"DMRA"},"owners":[{"id":70026,"kind":"person","name":"Firmani Lori","position":1,"cik":"0001808248","reported_name":"Firmani Lori","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CFO"}}],"security":"Restricted Stock Units","published_at":"2025-07-08T20:00:04.000Z","date":"2025-07-03","kind":"exercise","planned":false,"acquired":false,"shares":374,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents the right to receive, at settlement, one share of common stock of the Issuer. This transaction represents the settlement of RSUs in shares of common stock on their scheduled vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This award was granted on January 3, 2024. One-third of the RSUs subject to the award vested on January 3, 2025 and one-sixth of the RSUs subject to the award award will vest ratably every six months thereafter, assuming continued employment through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"This award was granted on January 3, 2024. One-third of the RSUs subject to the award vested on January 3, 2025 and one-sixth of the RSUs subject to the award award will vest ratably every six months thereafter, assuming continued employment through the applicable vesting date."}],"balance_after":1100,"derivative":{"underlying":"Common Stock","underlying_shares":374},"source":{"system":"sec-edgar","filing":"0000950170-25-094572","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1808248/000095017025094572/ownership.xml","form_type":"4"}},{"id":1090681,"issuer":{"id":4602,"kind":"organization","name":"Damora Therapeutics, Inc.","symbol":"DMRA"},"owners":[{"id":70026,"kind":"person","name":"Firmani Lori","position":1,"cik":"0001808248","reported_name":"Firmani Lori","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CFO"}}],"security":"Common Stock","published_at":"2025-07-08T20:00:04.000Z","date":"2025-07-03","kind":"sale","planned":false,"acquired":false,"shares":147,"price":3.39,"value":498.33,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares sold to cover tax obligations in connection with the vesting of the RSUs listed in Table II. This sale is mandated by the Issuer's election under its 2020 Equity Incentive Plan and does not represent a discretionary trade by the Reporting Person."}],"balance_after":692,"source":{"system":"sec-edgar","filing":"0000950170-25-094572","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808248/000095017025094572/ownership.xml","form_type":"4"}},{"id":1090680,"issuer":{"id":4602,"kind":"organization","name":"Damora Therapeutics, Inc.","symbol":"DMRA"},"owners":[{"id":70026,"kind":"person","name":"Firmani Lori","position":1,"cik":"0001808248","reported_name":"Firmani Lori","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CFO"}}],"security":"Common Stock","published_at":"2025-07-08T20:00:04.000Z","date":"2025-07-03","kind":"exercise","planned":false,"acquired":true,"shares":374,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents the right to receive, at settlement, one share of common stock of the Issuer. This transaction represents the settlement of RSUs in shares of common stock on their scheduled vesting date."}],"balance_after":839,"source":{"system":"sec-edgar","filing":"0000950170-25-094572","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808248/000095017025094572/ownership.xml","form_type":"4"}},{"id":1308213,"issuer":{"id":4602,"kind":"organization","name":"Damora Therapeutics, Inc.","symbol":"DMRA"},"owners":[{"id":70026,"kind":"person","name":"Firmani Lori","position":1,"cik":"0001808248","reported_name":"Firmani Lori","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CFO"}}],"security":"Stock Option (right to buy)","published_at":"2025-01-07T21:00:06.000Z","date":"2025-01-03","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the shares subject to such option will vest and become exercisable on January 3, 2026 and the remainder of the shares vest in substantially equal monthly installments for a period of 36 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":5000,"derivative":{"exercise_price":5.7,"expiration_date":"2035-01-03","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0000950170-25-002813","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1808248/000095017025002813/ownership.xml","form_type":"4"}},{"id":1308212,"issuer":{"id":4602,"kind":"organization","name":"Damora Therapeutics, Inc.","symbol":"DMRA"},"owners":[{"id":70026,"kind":"person","name":"Firmani Lori","position":1,"cik":"0001808248","reported_name":"Firmani Lori","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CFO"}}],"security":"Restricted Stock Units","published_at":"2025-01-07T21:00:06.000Z","date":"2025-01-03","kind":"exercise","planned":false,"acquired":false,"shares":726,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents the right to receive, at settlement, one share of common stock of the Issuer. This transaction represents the settlement of RSUs in shares of common stock on their scheduled vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This award was granted on January 3, 2024. One-third of the RSUs subject to the award vested on January 3, 2025 and one-sixth of the RSUs subject to the award award will vest ratably every six months thereafter, assuming continued employment through the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"This award was granted on January 3, 2024. One-third of the RSUs subject to the award vested on January 3, 2025 and one-sixth of the RSUs subject to the award award will vest ratably every six months thereafter, assuming continued employment through the applicable vesting date."}],"balance_after":1474,"derivative":{"underlying":"Common Stock","underlying_shares":726},"source":{"system":"sec-edgar","filing":"0000950170-25-002813","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1808248/000095017025002813/ownership.xml","form_type":"4"}},{"id":1308211,"issuer":{"id":4602,"kind":"organization","name":"Damora Therapeutics, Inc.","symbol":"DMRA"},"owners":[{"id":70026,"kind":"person","name":"Firmani Lori","position":1,"cik":"0001808248","reported_name":"Firmani Lori","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CFO"}}],"security":"Common Stock","published_at":"2025-01-07T21:00:06.000Z","date":"2025-01-03","kind":"sale","planned":false,"acquired":false,"shares":261,"price":5.63,"value":1469.43,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares sold to cover tax obligations in connection with the vesting of the RSUs listed in Table II. This sale is mandated by the Issuer's election under its 2020 Equity Incentive Plan and does not represent a discretionary trade by the Reporting Person."}],"balance_after":465,"source":{"system":"sec-edgar","filing":"0000950170-25-002813","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808248/000095017025002813/ownership.xml","form_type":"4"}},{"id":1308210,"issuer":{"id":4602,"kind":"organization","name":"Damora Therapeutics, Inc.","symbol":"DMRA"},"owners":[{"id":70026,"kind":"person","name":"Firmani Lori","position":1,"cik":"0001808248","reported_name":"Firmani Lori","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CFO"}}],"security":"Common Stock","published_at":"2025-01-07T21:00:06.000Z","date":"2025-01-03","kind":"exercise","planned":false,"acquired":true,"shares":726,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents the right to receive, at settlement, one share of common stock of the Issuer. This transaction represents the settlement of RSUs in shares of common stock on their scheduled vesting date."}],"balance_after":726,"source":{"system":"sec-edgar","filing":"0000950170-25-002813","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808248/000095017025002813/ownership.xml","form_type":"4"}},{"id":1387595,"issuer":{"id":4602,"kind":"organization","name":"Damora Therapeutics, Inc.","symbol":"DMRA"},"owners":[{"id":70026,"kind":"person","name":"Firmani Lori","position":1,"cik":"0001808248","reported_name":"Firmani Lori","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CFO"}}],"security":"Stock Option (right to buy)","published_at":"2024-10-11T21:00:05.000Z","date":"2024-10-09","kind":"grant","planned":false,"acquired":true,"shares":13000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to such option vest in 48 equal monthly installments over four years from the Award Date, subject in each case to the grantee's continued service through the applicable vesting date."}],"balance_after":13000,"derivative":{"exercise_price":7.49,"expiration_date":"2034-10-09","underlying":"Common Stock","underlying_shares":13000},"source":{"system":"sec-edgar","filing":"0000950170-24-114385","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808248/000095017024114385/ownership.xml","form_type":"4"}},{"id":2970043,"issuer":{"id":115726,"kind":"organization","name":"F-star Therapeutics, Inc.","symbol":"FSTX"},"owners":[{"id":70026,"kind":"person","name":"Firmani Lori","position":1,"cik":"0001808248","reported_name":"Firmani Lori","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Finance and Treasurer"}}],"security":"Restricted Stock Units","published_at":"2020-11-23T16:12:44.000Z","date":"2020-11-19","kind":"exercise","acquired":false,"shares":3750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units (\"RSUs\") converted into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"All unvested issued and outstanding RSUs accelerated and vested in full in connection with the closing of the business combination with F-star Therapeutics Limited."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"All unvested issued and outstanding RSUs accelerated and vested in full in connection with the closing of the business combination with F-star Therapeutics Limited."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3750},"source":{"system":"sec-edgar","filing":"0000905718-20-001130","document":"springbank_fm4nov192020.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1808248/000090571820001130/springbank_fm4nov192020.xml","form_type":"4"}},{"id":2970042,"issuer":{"id":115726,"kind":"organization","name":"F-star Therapeutics, Inc.","symbol":"FSTX"},"owners":[{"id":70026,"kind":"person","name":"Firmani Lori","position":1,"cik":"0001808248","reported_name":"Firmani Lori","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Finance and Treasurer"}}],"security":"Common Stock","published_at":"2020-11-23T16:12:44.000Z","date":"2020-11-20","kind":"sale","acquired":false,"shares":175,"price":4.76,"value":833.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.64 to $4.88 per share. The Reporting Person undertakes to provide to Issuer any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein."}],"balance_after":17867,"source":{"system":"sec-edgar","filing":"0000905718-20-001130","document":"springbank_fm4nov192020.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1808248/000090571820001130/springbank_fm4nov192020.xml","form_type":"4"}},{"id":2970041,"issuer":{"id":115726,"kind":"organization","name":"F-star Therapeutics, Inc.","symbol":"FSTX"},"owners":[{"id":70026,"kind":"person","name":"Firmani Lori","position":1,"cik":"0001808248","reported_name":"Firmani Lori","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Finance and Treasurer"}}],"security":"Common Stock","published_at":"2020-11-23T16:12:44.000Z","date":"2020-11-19","kind":"grant","acquired":true,"shares":12500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units (\"RSUs\") converted into common stock on a one-for-one basis."}],"balance_after":18042,"source":{"system":"sec-edgar","filing":"0000905718-20-001130","document":"springbank_fm4nov192020.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808248/000090571820001130/springbank_fm4nov192020.xml","form_type":"4"}},{"id":2970040,"issuer":{"id":115726,"kind":"organization","name":"F-star Therapeutics, Inc.","symbol":"FSTX"},"owners":[{"id":70026,"kind":"person","name":"Firmani Lori","position":1,"cik":"0001808248","reported_name":"Firmani Lori","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Finance and Treasurer"}}],"security":"Common Stock","published_at":"2020-11-23T16:12:44.000Z","date":"2020-11-19","kind":"exercise","acquired":true,"shares":3750,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units (\"RSUs\") converted into common stock on a one-for-one basis."}],"balance_after":5542,"source":{"system":"sec-edgar","filing":"0000905718-20-001130","document":"springbank_fm4nov192020.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808248/000090571820001130/springbank_fm4nov192020.xml","form_type":"4"}}]}